Corrigendum to "Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE" [J. Autoimmun. 58, (2015), 67-77] Doi: 10.1016/j.jaut.2015.01.006;Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE

Journal of Autoimmunity

Volumn 58, Issue , 2015, Pages 67-77

  Detanico, Thiago ^a,b   Guo, Wenzhong ^a,c   Wysocki, Lawrence J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c SORRENTO THERAPEUTICS   (United States)

Author keywords

Anti nuclear; Autoantibodies; Lupus; Somatic hypermutation

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ANTINUCLEAR ANTIBODY; ARGININE; B LYMPHOCYTE RECEPTOR; DNA; HISTONE; IMMUNOGLOBULIN G ANTIBODY; NUCLEOSOME ANTIBODY; AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); CYTIDINE DEAMINASE; DNA NUCLEOTIDYLEXOTRANSFERASE; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CELL EXPANSION; CLONAL EVOLUTION; CODON USAGE; CONTROLLED STUDY; EXPERIMENTAL SYSTEMIC LUPUS ERYTHEMATOSUS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYBRIDOMA; IGK GENE; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; JH GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE GENE; WILD TYPE; ANIMAL; BLOOD; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MUTANT MOUSE STRAIN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; CYTIDINE DEAMINASE; DISEASE MODELS, ANIMAL; DNA; DNA NUCLEOTIDYLEXOTRANSFERASE; HISTONES; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84930383835     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.04.001     Document Type: Erratum

References (103)

1. Kotzin B.L. Systemic lupus erythematosus. Cell 1996, 85:303-306.
2. Erikson J., Radic M.Z., Camper S.A., Hardy R.R., Carmack C., Weigert M. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 1991, 349:331-334.
3. Guth A.M., Zhang X., Smith D., Detanico T., Wysocki L.J. Chromatin specificity of anti-double-stranded DNA antibodies and a role for Arg residues in the third complementarity-determining region of the heavy chain. JImmunol 2003, 171:6260-6266.
4. Gay D., Saunders T., Camper S., Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. JExp Med 1993, 177:999-1008.
5. Radic M.Z., Erikson J., Litwin S., Weigert M. Blymphocytes may escape tolerance by revising their antigen receptors. JExp Med 1993, 177:1165-1173.
6. Friedmann D., Yachimovich N., Mostoslavsky G., Pewzner-Jung Y., Ben-Yehuda A., Rajewsky K., et al. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. JImmunol 1999, 162:4406-4416.
7. Li H., Jiang Y., Prak E.L., Radic M., Weigert M. Editors and editing of anti-DNA receptors. Immunity 2001, 15:947-957.
8. Yachimovich-Cohen N., Fischel R., Bachar N., Yarkoni Y., Eilat D. Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors. Eur J Immunol 2003, 33:2469-2478.
9. Li Y., Louzoun Y., Weigert M. Editing anti-DNA B cells by Vlambdax. JExp Med 2004, 199:337-346.
10. Khan S.N., Witsch E.J., Goodman N.G., Panigrahi A.K., Chen C., Jiang Y., et al. Editing and escape from editing in anti-DNA B cells. Proc Natl Acad Sci U S A 2008, 105:3861-3866.
11. Marion T.N., Bothwell A.L., Briles D.E., Janeway C.A. IgG anti-DNA autoantibodies within an individual autoimmune mouse are the products of clonal selection. JImmunol 1989, 142:4269-4274.
12. Shlomchik M., Mascelli M., Shan H., Radic M.Z., Pisetsky D., Marshak-Rothstein A., et al. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. JExp Med 1990, 171:265-292.
13. Portanova J.P., Creadon G., Zhang X., Smith D.S., Kotzin B.L., Wysocki L.J. An early post-mutational selection event directs expansion of autoreactive B cells in murine lupus. Mol Immunol 1995, 32:117-135.
14. Schroeder K., Herrmann M., Winkler T.H. The role of somatic hypermutation in the generation of pathogenic antibodies in SLE. Autoimmunity 2013, 46:121-127.
15. Detanico T., St Clair J.B., Aviszus K., Kirchenbaum G., Guo W., Wysocki L.J. Somatic mutagenesis in autoimmunity. Autoimmunity 2013, 46:102-114.
16. Brard F., Shannon M., Prak E.L., Litwin S., Weigert M. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. JExp Med 1999, 190:691-704.
17. Mandik-Nayak L., Seo S.J., Sokol C., Potts K.M., Bui A., Erikson J. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. JExp Med 1999, 189:1799-1814.
18. Sekiguchi D.R., Jainandunsing S.M., Fields M.L., Maldonado M.A., Madaio M.P., Erikson J., et al. Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. JImmunol 2002, 168:4142-4153.
19. Steeves M.A., Marion T.N. Tolerance to DNA in (NZB x NZW)F1 mice that inherit an anti-DNA V(H) as a conventional micro H chain transgene but not as a V(H) knock-in transgene. JImmunol 2004, 172:6568-6577.
20. Chen C., Li H., Tian Q., Beardall M., Xu Y., Casanova N., et al. Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice. JImmunol 2006, 176:5183-5190.
21. Liu Y., Li L., Kumar K.R., Xie C., Lightfoot S., Zhou X.J., et al. Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. JImmunol 2007, 179:1340-1352.
22. Li Z., Schettino E.W., Padlan E.A., Ikematsu H., Casali P. Structure-function analysis of a lupus anti-DNA autoantibody: central role of the heavy chain complementarity-determining region 3 Arg in binding of double- and single-stranded DNA. Eur J Immunol 2000, 30:2015-2026.
23. Mietzner B., Tsuiji M., Scheid J., Velinzon K., Tiller T., Abraham K., et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A 2008, 105:9727-9732.
24. Zhang J., Jacobi A.M., Wang T., Diamond B. Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells. Mol Med 2008, 14:675-681.
25. Wellmann U., Letz M., Herrmann M., Angermuller S., Kalden J.R., Winkler T.H. The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci U S A 2005, 102:9258-9263.
26. Gilfillan S., Dierich A., Lemeur M., Benoist C., Mathis D. Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 1993, 261:1175-1178.
27. Komori T., Okada A., Stewart V., Alt F.W. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 1993, 261:1171-1175.
28. Guo W., Smith D., Aviszus K., Detanico T., Heiser R.A., Wysocki L.J. Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. JExp Med 2010, 207:2225-2237.
29. Molano I.D., Wloch M.K., Alexander A.A., Watanabe H., Gilkeson G.S. Effect of a genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production by C57BL6 Fas(lpr) mice. Clin Immunol 2000, 94:24-32.
30. Molano I.D., Redmond S., Sekine H., Zhang X.K., Reilly C., Hutchison F., et al. Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice. Clin Immunol 2003, 107:186-197.
31. Tiegs S.L., Russell D.M., Nemazee D. Receptor editing in self-reactive bone marrow B cells. JExp Med 1993, 177:1009-1020.
32. Fournier E.M., Velez M.G., Leahy K., Swanson C.L., Rubtsov A.V., Torres R.M., et al. Dual-reactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice. JExp Med 2012, 209:1797-1812.
33. Nossal G.J., Makela O. Kinetic studies on the incidence of cells appearing to form two antibodies. JImmunol 1962, 88:604-612.
34. Pauza M.E., Rehmann J.A., LeBien T.W. Unusual patterns of immunoglobulin gene rearrangement and expression during human B cell ontogeny: human B cells can simultaneously express cell surface kappa and lambda light chains. JExp Med 1993, 178:139-149.
35. Giachino C., Padovan E., Lanzavecchia A. kappa+lambda+ dual receptor B cells are present in the human peripheral repertoire. JExp Med 1995, 181:1245-1250.
36. Gerdes T., Wabl M. Autoreactivity and allelic inclusion in a B cell nuclear transfer mouse. Nat Immunol 2004, 5:1282-1287.
37. Rezanka L.J., Kenny J.J., Longo D.L. Dual isotype expressing B cells [kappa(+)/lambda(+)] arise during the ontogeny of B cells in the bone marrow of normal nontransgenic mice. Cell Immunol 2005, 238:38-48.
38. Casellas R., Zhang Q., Zheng N.Y., Mathias M.D., Smith K., Wilson P.C. Igkappa allelic inclusion is a consequence of receptor editing. JExp Med 2007, 204:153-160.
39. Kalinina O., Doyle-Cooper C.M., Miksanek J., Meng W., Prak E.L., Weigert M.G. Alternative mechanisms of receptor editing in autoreactive B cells. Proc Natl Acad Sci U S A 2011, 108:7125-7130.
40. Kenny J.J., Rezanka L.J., Lustig A., Fischer R.T., Yoder J., Marshall S., et al. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. JImmunol 2000, 164:4111-4119.
41. Li Y., Li H., Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. JExp Med 2002, 195:181-188.
42. Liu S., Velez M.G., Humann J., Rowland S., Conrad F.J., Halverson R., et al. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens. JImmunol 2005, 175:5067-5076.
43. Huang H., Kearney J.F., Grusby M.J., Benoist C., Mathis D. Induction of tolerance in arthritogenic B cells with receptors of differing affinity for self-antigen. Proc Natl Acad Sci U S A 2006, 103:3734-3739.
44. Radic M.Z., Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 1994, 12:487-520.
45. Rozzo S.J., Allard J.D., Choubey D., Vyse T.J., Izui S., Peltz G., et al. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 2001, 15:435-443.
46. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
47. Guth A., Detanico T., Smith D., Tung K.S., Bonorino C., Wysocki L.J. Spontaneous autoimmunity in mice that carry an IghV partial transgene: a required arginine in VHCDR3. Lupus 2009, 18:299-308.
48. Li Q.Z., Zhou J., Wandstrat A.E., Carr-Johnson F., Branch V., Karp D.R., et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol 2007, 147:60-70.
49. Harris J.F., Hawley R.G., Hawley T.S., Crawford-Sharpe G.C. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6. JImmunol Methods 1992, 148:199-207.
50. Sanchez P., Nadel B., Cazenave P.A. Vlambda-J lambda rearrangements are restricted within a V-J-C recombination unit in the mouse. Eur J Immunol 1991, 21:907-911.
51. Johnston C.M., Wood A.L., Bolland D.J., Corcoran A.E. Complete sequence assembly and characterization of the C57BL/6 mouse Ig heavy chain V region. JImmunol 2006, 176:4221-4234.
52. Brekke K.M., Garrard W.T. Assembly and analysis of the mouse immunoglobulin kappa gene sequence. Immunogenetics 2004, 56:490-505.
53. Lefranc M.P., Giudicelli V., Ginestoux C., Bodmer J., Muller W., Bontrop R., et al. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 1999, 27:209-212.
54. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. JMol Biol 1990, 215:403-410.
55. Southern E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. JMol Biol 1975, 98:503-517.
56. Tillman D.M., Jou N.T., Hill R.J., Marion T.N. Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice. JExp Med 1992, 176:761-779.
57. Marion T.N., Tillman D.M., Jou N.T. Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB x NZW)F1 mouse. JImmunol 1990, 145:2322-2332.
58. Wloch M.K., Alexander A.L., Pippen A.M., Pisetsky D.S., Gilkeson G.S. Differences in V kappa gene utilization and VH CDR3 sequence among anti-DNA from C3H-lpr mice and lupus mice with nephritis. Eur J Immunol 1996, 26:2225-2233.
59. Losman M.J., Fasy T.M., Novick K.E., Monestier M. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. JImmunol 1992, 148:1561-1569.
60. Krishnan M.R., Marion T.N. Comparison of the frequencies of arginines in heavy chain CDR3 of antibodies expressed in the primary B-cell repertoires of autoimmune-prone and normal mice. Scand J Immunol 1998, 48:223-232.
61. Eilat D., Fischel R. Recurrent utilization of genetic elements in V regions of antinucleic acid antibodies from autoimmune mice. JImmunol 1991, 147:361-368.
62. Eilat D., Webster D.M., Rees A.R. Vregion sequences of anti-DNA and anti-RNA autoantibodies from NZB/NZW F1 mice. JImmunol 1988, 141:1745-1753.
63. Tsao B.P., Cantor R.M., Kalunian K.C., Chen C.J., Badsha H., Singh R., et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. JClin Invest 1997, 99:725-731.
64. Atencio S., Amano H., Izui S., Kotzin B.L. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. JImmunol 2004, 172:4159-4166.
65. Gubbels M.R., Jorgensen T.N., Metzger T.E., Menze K., Steele H., Flannery S.A., et al. Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice. JImmunol 2005, 175:6190-6196.
66. Jorgensen T.N., Thurman J., Izui S., Falta M.T., Metzger T.E., Flannery S.A., et al. Genetic susceptibility to polyI: C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice. Genes Immun 2006, 7:555-567.
67. Vyse T.J., Rozzo S.J., Drake C.G., Izui S., Kotzin B.L. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice. JImmunol 1997, 158:5566-5574.
68. Martin S.W., Goodnow C.C. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat Immunol 2002, 3:182-188.
69. Horikawa K., Martin S.W., Pogue S.L., Silver K., Peng K., Takatsu K., et al. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. JExp Med 2007, 204:759-769.
70. Gitlin A.D., Shulman Z., Nussenzweig M.C. Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature 2014, 509:637-640.
71. Makdasi E., Eilat D. Lchain allelic inclusion does not increase autoreactivity in lupus-prone New Zealand Black/New Zealand White mice. JImmunol (Baltimore, Md:1950) 2013.
72. Krishnan M.R., Jou N.T., Marion T.N. Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies. JImmunol 1996, 157:2430-2439.
73. Radic M.Z., Mackle J., Erikson J., Mol C., Anderson W.F., Weigert M. Residues that mediate DNA binding of autoimmune antibodies. JImmunol 1993, 150:4966-4977.
74. Shapiro G.S., Ellison M.C., Wysocki L.J. Sequence-specific targeting of two bases on both DNA strands by the somatic hypermutation mechanism. Mol Immunol 2003, 40:287-295.
75. Cocca B.A., Cline A.M., Radic M.Z. Blebs and apoptotic bodies are B cell autoantigens. JImmunol 2002, 169:159-166.
76. Radic M., Marion T., Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. JImmunol 2004, 172:6692-6700.
77. Taylor J.J., Martinez R.J., Titcombe P.J., Barsness L.O., Thomas S.R., Zhang N., et al. Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen. JExp Med 2012, 209:2065-2077.
78. Keech C.L., Farris A.D., Beroukas D., Gordon T.P., McCluskey J. Cognate T cell help is sufficient to trigger anti-nuclear autoantibodies in naive mice. JImmunol 2001, 166:5826-5834.
79. Culton D.A., O'Conner B.P., Conway K.L., Diz R., Rutan J., Vilen B.J., et al. Early preplasma cells define a tolerance checkpoint for autoreactive B cells. JImmunol 2006, 176:790-802.
80. Zhu Y., Nonoyama S., Morio T., Muramatsu M., Honjo T., Mizutani S. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. JMed Dent Sci 2003, 50:41-46.
81. Zaheen A., Boulianne B., Parsa J.-Y.Y., Ramachandran S., Gommerman J.L., Martin A. AID constrains germinal center size by rendering B cells susceptible to apoptosis. Blood 2009, 114:547-554.
82. Qin H., Suzuki K., Nakata M., Chikuma S., Izumi N., Huong L Thi, et al. Activation-induced cytidine deaminase expression in CD4+ T cells is associated with a unique IL-10-producing subset that increases with age. PloS One 2010, 6.
83. Péron S., Laffleur B., Denis-Lagache N., Cook-Moreau J., Tinguely A., Delpy L., et al. AID-driven deletion causes immunoglobulin heavy chain locus suicide recombination in B cells. Science (New York, NY) 2012, 336:931-934.
84. Kuraoka M., Holl T.M., Liao D., Womble M., Cain D.W., Reynolds A.E., et al. Activation-induced cytidine deaminase mediates central tolerance in B cells. Proc Natl Acad Sci U S A 2011, 108:11560-11565.
85. Meyers G., Ng Y.-S.S., Bannock J.M., Lavoie A., Walter J.E., Notarangelo L.D., et al. Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc Natl Acad Sci U S A 2011, 108:11554-11559.
86. Hogenbirk M.A., Heideman M.R., Velds A., van den Berk P.C., Kerkhoven R.M., van Steensel B., et al. Differential programming of B cells in AID deficient mice. PloS One 2012, 8.
87. Liang Z., Chen C., Mohan C. Molecular signatures of anti-nuclear antibodies: contributions of specific light chain residues and a novel New Zealand Black V kappa 1 germline gene. JImmunol 2003, 171:3886-3894.
88. Boes M., Schmidt T., Linkemann K., Beaudette B.C., Marshak-Rothstein A., Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A 2000, 97:1184-1189.
89. Werwitzke S., Trick D., Kamino K., Matthias T., Kniesch K., Schlegelberger B., et al. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Arthritis Rheum 2005, 52:3629-3638.
90. Jiang C., Foley J., Clayton N., Kissling G., Jokinen M., Herbert R., et al. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. JImmunol 2007, 178:7422-7431.
91. Jiang C., Zhao M.L., Scearce R.M., Diaz M. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum 2011, 63:1086-1096.
92. Mannoor K., Matejuk A., Xu Y., Beardall M., Chen C. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. JImmunol 2012, 188:3628-3638.
93. Conde C., Weller S., Gilfillan S., Marcellin L., Martin T., Pasquali J.L. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice. JImmunol 1998, 161:7023-7030.
94. Feeney A.J., Lawson B.R., Kono D.H., Theofilopoulos A.N. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice. JImmunol 2001, 167:3486-3493.
95. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science 2003, 301:1374-1377.
96. Brinkman K., Termaat R., Berden J.H., Smeenk R.J. Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunol Today 1990, 11:232-234.
97. Termaat R.M., Brinkman K., van Gompel F., van den Heuvel L.P., Veerkamp J.H., Smeenk R.J., et al. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. JAutoimmun 1990, 3:531-545.
98. Brinkman K., Termaat R.M., de Jong J., van den Brink H.G., Berden J.H., Smeenk R.J. Cross-reactive binding patterns of monoclonal antibodies to DNA are often caused by DNA/anti-DNA immune complexes. Res Immunol 1989, 140:595-612.
99. Subiza J.L., Caturla A., Pascual-Salcedo D., Chamorro M.J., Gazapo E., Figueredo M.A., et al. DNA-anti-DNA complexes account for part of the antihistone activity found in patients with systemic lupus erythematosus. Arthritis Rheum 1989, 32:406-412.
100. Shapiro G.S., Aviszus K., Murphy J., Wysocki L.J. Evolution of Ig DNA sequence to target specific base positions within codons for somatic hypermutation. JImmunol 2002, 168:2302-2306.
101. Wagner S.D., Milstein C., Neuberger M.S. Codon bias targets mutation. Nature 1995, 376:732.
102. Tucker R.M., Roark C.L., Santiago-Raber M.L., Izui S., Kotzin B.L. Association between nuclear antigens and endogenous retrovirus in the generation of autoantibody responses in murine lupus. Arthritis Rheum 2004, 50:3626-3636.
103. Mouquet H., Scheid J.F., Zoller M.J., Krogsgaard M., Ott R.G., Shukair S., et al. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 2010, 467:591-595.